Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

125 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine safety and patients' satisfaction when using Tears Again to treat Dry Eye Symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Ocular Comfort With ISTA Tears vs Systane

NCT01650584

Dry Eye Disease

COMPLETED NA

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

NCT01010282

Dry Eye Syndrome

COMPLETED NA

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

NCT05238597

Dry Eye Disease

COMPLETED PHASE2

A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease

NCT05424549

Dry Eye Syndromes

COMPLETED PHASE2

Study Evaluating Techniques for Measuring Tear Production

NCT05497479

Dry Eye Disease

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tears Again

All subjects shall be treated with Tears Again.

Group Type EXPERIMENTAL

Tears Again

Intervention Type DRUG

Liposome Eye Spray

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tears Again

Liposome Eye Spray

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Suffer from at least two of the following ocular symptoms: burning, stinging, excessive tearing, dryness, grittiness, foreign body sensation ( including patients suffering from blepharitis).
* Use artificial tears or any other treatment for these symptoms three or more times a day.

Exclusion Criteria

* Known hypersensitivity to Phenoxyethanol.
* Pregnant and lactating women.
* Receive other ophthalmic medication (except for eyelid hygiene preparations).
* Graft-versus-host disease patients.
* Participated during the last month in another clinical trial.

Minimum Eligible Age

25 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No